The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.
about
Immune Cells in Cancer Therapy and Drug DeliveryA new insight into viral proteins as Immunomodulatory therapeutic agents: KSHV vOX2 a homolog of human CD200 as a potent anti-inflammatory proteinCharacterization of CD200 Ectodomain SheddingA thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest.Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions.Role of immune-regulatory cells in skin pathology.CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy.L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis.UV light B-mediated inhibition of skin catalase activity promotes Gr-1+ CD11b+ myeloid cell expansion.Over-Expression of CD200 Predicts Poor Prognosis in Cutaneous Squamous Cell CarcinomaProgrammed cell removal: a new obstacle in the road to developing cancer.Treatment failure in patients with HPV 16-induced vulvar intraepithelial neoplasia: understanding different clinical responses to immunotherapy.A Truncated form of CD200 (CD200S) Expressed on Glioma Cells Prolonged Survival in a Rat Glioma Model by Induction of a Dendritic Cell-Like Phenotype in Tumor-Associated Macrophages.Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response.Cancer Stem Cells in Squamous Cell Carcinoma.Blockade of Myd88 signaling induces antitumor effects by skewing the immunosuppressive function of myeloid-derived suppressor cells.Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis.The role of tumor expression of CD200 in tumor formation, metastasis and susceptibility to T lymphocyte adoptive transfer therapy.Expression of selected regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer and their clinical significance.A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotionMyogenic properties of human mesenchymal stem cells derived from three different sources.A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T-cell function and therapy of murine leukemia.Surface CD200 and CD200R antigens on lymphocytes in advanced gastric cancer: a new potential target for immunotherapyCD200:CD200R-Mediated Regulation of Immunity
P2860
Q26747061-F7D2BDFF-B70F-4E7C-B1CA-51D747720CF8Q26751623-B02B6B5D-F06D-4183-83F2-722CD6F2EE78Q28551557-B915B180-92F9-4AAF-8D50-BD5386E7D343Q30410836-BF0AEA99-D5B3-4A23-A4C6-D49B2D0AE55AQ34154823-63DC9006-9B8D-4E61-907D-C0C1CF50A11BQ34417553-80F76E71-85F5-44B8-B7B1-8A2F93C583BDQ34976095-E463FC96-AFC7-4CFA-B317-C663B1C4B37AQ35154253-EFE412D2-FD80-47B8-B7FC-C3736CDF1D96Q35722475-39E1515D-B389-481A-8D44-2863E319FFC8Q36771508-E8858DC8-F6ED-417A-84EB-5020BBE7C81BQ37967032-E37D5FF1-E091-401D-A713-D1E5A471C1D9Q38036688-A8B6E19A-8769-4FC4-AFF9-384F9CDDCBB1Q38775934-601AF70A-0E1D-4C0A-AE38-ABC538D5C21FQ38941113-4A397693-17AC-4B8B-9A16-FF669A760FFFQ38952569-3F874799-6C38-4259-BE91-07380C9DB610Q38957139-1B37ACB0-73C3-405E-8F19-68AF7AE1D540Q39237839-65A7D405-8E0E-48EA-9909-7BF4813C8CD7Q39532047-A3F91B34-2E59-4CEB-9633-5403D290F160Q39567775-E2381A49-BB4A-401D-941D-0362143AC7C9Q41474685-88C1E1D8-271B-41A0-9ECB-19292259D019Q41863998-66A47E3D-86F8-4A2A-ADD5-BF61584A2285Q42376556-228558E0-DB78-4B3A-9139-1322CD478E30Q42541724-42EF783F-147D-4677-AB59-2099D958DDCEQ42604796-FD5C5988-8F85-47F0-AC07-3F07FB56F341Q47637581-A54ED71E-E4E6-4E83-A98C-AB4E35E7883EQ58588552-E8C754D1-95D4-47A1-8DA5-7787C3738A9EQ58692091-A9EB3CD0-26E6-4086-9CE0-CEAA5EDF330D
P2860
The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The immunosuppressive surface ...... ty of squamous cell carcinoma.
@ast
The immunosuppressive surface ...... ty of squamous cell carcinoma.
@en
type
label
The immunosuppressive surface ...... ty of squamous cell carcinoma.
@ast
The immunosuppressive surface ...... ty of squamous cell carcinoma.
@en
prefLabel
The immunosuppressive surface ...... ty of squamous cell carcinoma.
@ast
The immunosuppressive surface ...... ty of squamous cell carcinoma.
@en
P2093
P2860
P1433
P1476
The immunosuppressive surface ...... ity of squamous cell carcinoma
@en
P2093
David M Owens
Edward B Desciak
Magda Stumpfova
Yehuda D Eliezri
P2860
P304
P356
10.1158/0008-5472.CAN-09-4380
P407
P50
P577
2010-03-23T00:00:00Z